Eshbal Functional Food Inc.

Eshbal Functional Food Inc. is a food-tech company specializing in the development and manufacturing of gluten-free and "Better for You" food products and dietary supplements. The company's mission is to make healthy eating accessible and enjoyable, aiming to improve quality of life through functional food solutions. While its primary operational base and manufacturing facilities are located in Kibbutz Ma'anit, Israel, the publicly traded entity is incorporated in British Columbia, Canada, with a North American office in Vancouver.

Eshbal offers a diverse portfolio of over 300 SKUs, including more than 80 proprietary gluten-free items. Its product range encompasses flours, baked goods, protein snacks, dietary supplements, and superfoods, often utilizing natural ingredients like teff and chia. The company also develops sugar-free, vegan, and low-carb options, as well as sugar substitutes, sports nutrition products, fortified powders, cereals, spreads, and syrups. These products are distributed across retail, foodservice, and online channels, catering to various dietary needs and preferences.

Eshbal Functional Food Inc. is a publicly traded company on the TSX Venture Exchange under the ticker symbol ESBL. The company has been actively pursuing a North American expansion strategy, marked by recent acquisitions including Gluten Free Nation in February 2026 and a majority interest in Dare to Be Different Foods in November 2025. Leadership includes CEO Tomer Bar-Meir, CFO Gadi Levin, and CCO Avi Markus, with Yuval Levy serving as Chairman. In March 2026, Natalie Ben-Zur was appointed as VP, Online & Business Operations for North America, further strengthening the company's focus on this key market.

Latest updates

Eshbal's Margin Gains Offset by Rising Costs, Contingent Share Agreement

Event summary

  • Eshbal Functional Foods Inc. reported 2025 revenues of US $13.8 million, a 20% increase year-over-year.
  • Gross margin improved to 25.4% from 22.7% in 2024, but operating loss widened to $0.3 million from operating income of $0.6 million in the prior year.
  • The net loss for the year was $2.9 million, primarily due to one-time listing expenses.
  • Eshbal entered into a side letter agreement with Starcall Broadcasting LLC regarding potential share issuance related to Gluten Free Nation milestones, potentially triggering a cash payment to Starcall.

The big picture

Eshbal's strategy of acquiring and integrating smaller, specialized food brands to build a scalable platform is facing immediate challenges. While revenue growth is positive, the increased operating loss and contingent share agreement indicate that Eshbal's public listing and acquisition strategy are creating significant integration and governance complexities. The company's ability to achieve profitability will hinge on its ability to streamline operations and manage these complexities effectively.

What we're watching

Governance Dynamics
The contingent cash payment to Starcall highlights potential dilution risk and underscores the complexities of the Gluten Free Nation acquisition structure, which warrants close monitoring.
Execution Risk
The widening operating loss despite revenue growth suggests that Eshbal's transition to a public company and integration of acquired brands are creating significant operational headwinds that need to be addressed.
Margin Sustainability
Whether Eshbal can sustain the improved gross margin achieved in 2025 will depend on its ability to control general and administrative expenses and realize synergies from its acquisitions.
CID: 744